Hartford Great Health Corp. Files 10-K/A Amendment
Ticker: HFUS · Form: 10-K/A · Filed: Mar 5, 2024 · CIK: 1482554
| Field | Detail |
|---|---|
| Company | Hartford Great Health CORP. (HFUS) |
| Form Type | 10-K/A |
| Filed Date | Mar 5, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K/A, Annual Report, Hartford Great Health Corp., SEC Filing, Financials
TL;DR
<b>Hartford Great Health Corp. has filed an amendment to its annual report for the fiscal year ending July 31, 2023, providing updated financial and corporate information.</b>
AI Summary
Hartford Great Health Corp. (HFUS) filed a Amended Annual Report (10-K/A) with the SEC on March 5, 2024. Hartford Great Health Corp. filed an amendment (10-K/A) to its annual report for the fiscal year ended July 31, 2023. The company was formerly known as Photoamigo, Inc., with a name change effective January 28, 2010. The aggregate market value of the registrant's common stock held by non-affiliates was $1,244,223 as of January 31, 2023. Hartford Great Health Corp. is incorporated in Nevada and its principal executive offices are located in Rosemead, California. The company has submitted electronically every Interactive Data File required for the preceding 12 months.
Why It Matters
For investors and stakeholders tracking Hartford Great Health Corp., this filing contains several important signals. This amendment provides updated information for the fiscal year 2023, which is crucial for investors to assess the company's current financial health and operational status. The filing includes details on the company's market capitalization of non-affiliates, offering insight into investor confidence and the stock's public valuation.
Risk Assessment
Risk Level: low — Hartford Great Health Corp. shows low risk based on this filing. The filing is an amendment to a 10-K, suggesting potential corrections or additions to previously reported information, but the content provided does not indicate significant new risks.
Analyst Insight
Review the full 10-K/A filing for specific details on any amendments made to the original 10-K to understand the nature of the updates.
Key Numbers
- 2023-07-31 — Fiscal Year End (Fiscal year ended July 31, 2023)
- 2024-03-05 — Filing Date (Conformed submission date)
- $1,244,223 — Market Value (Non-Affiliates) (As of January 31, 2023)
- 000-54439 — Commission File Number (SEC file number)
Key Players & Entities
- Hartford Great Health Corp. (company) — Registrant name
- Photoamigo, Inc. (company) — Former company name
- Nevada (jurisdiction) — State of incorporation
- Rosemead, California (location) — Principal executive offices
- January 28, 2010 (date) — Date of name change
- July 31, 2023 (date) — Fiscal year end
- $1,244,223 (dollar_amount) — Aggregate market value of common stock held by non-affiliates
- January 31, 2023 (date) — Date for market value calculation
FAQ
When did Hartford Great Health Corp. file this 10-K/A?
Hartford Great Health Corp. filed this Amended Annual Report (10-K/A) with the SEC on March 5, 2024.
What is a 10-K/A filing?
A 10-K/A is a amendment to a previously filed annual report, correcting or updating financial statements or disclosures. This particular 10-K/A was filed by Hartford Great Health Corp. (HFUS).
Where can I read the original 10-K/A filing from Hartford Great Health Corp.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Hartford Great Health Corp..
What are the key takeaways from Hartford Great Health Corp.'s 10-K/A?
Hartford Great Health Corp. filed this 10-K/A on March 5, 2024. Key takeaways: Hartford Great Health Corp. filed an amendment (10-K/A) to its annual report for the fiscal year ended July 31, 2023.. The company was formerly known as Photoamigo, Inc., with a name change effective January 28, 2010.. The aggregate market value of the registrant's common stock held by non-affiliates was $1,244,223 as of January 31, 2023..
Is Hartford Great Health Corp. a risky investment based on this filing?
Based on this 10-K/A, Hartford Great Health Corp. presents a relatively low-risk profile. The filing is an amendment to a 10-K, suggesting potential corrections or additions to previously reported information, but the content provided does not indicate significant new risks.
What should investors do after reading Hartford Great Health Corp.'s 10-K/A?
Review the full 10-K/A filing for specific details on any amendments made to the original 10-K to understand the nature of the updates. The overall sentiment from this filing is neutral.
Key Dates
- 2023-07-31: Fiscal Year End — Marks the end of the reporting period for the annual report.
- 2024-03-05: Filing Date — Date the 10-K/A amendment was filed with the SEC.
- 2010-01-28: Name Change — Date the company changed its name from Photoamigo, Inc. to Hartford Great Health Corp.
Filing Stats: 1,229 words · 5 min read · ~4 pages · Grade level 13 · Accepted 2024-03-05 17:14:49
Key Financial Figures
- $0.001 — ch registered Common stock, par value $0.001 par value HFUS OTC Markets Group
Filing Documents
- form10-ka.htm (10-K/A) — 81KB
- ex31-1.htm (EX-31.1) — 17KB
- ex31-2.htm (EX-31.2) — 16KB
- 0001493152-24-008884.txt ( ) — 332KB
- hfus-20230731.xsd (EX-101.SCH) — 3KB
- hfus-20230731_lab.xml (EX-101.LAB) — 35KB
- hfus-20230731_pre.xml (EX-101.PRE) — 23KB
- form10-ka_htm.xml (XML) — 7KB
SIGNATURES
SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. HARTFORD GREAT HEALTH CORP. Date: March 5, 2024 By: /s/ ROSE HONG WANG Rose Hong Wang Chief Executive Officer Pursuant to the requirements of the Securities Exchange Act of 1934 this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated. Name Title Date /s/ Rose Hong Wang Chief Executive Officer, President, Dir. March 5, 2024 Rose Hong Wang (Principal Executive Officer) /s/ Sheng-Yih Chang Chief Financial Officer, Dir March 5, 2024 Sheng-Yih Chang (Principal Accounting Officer) /s/ Yuan Lu Director March 5, 2024 Yuan Lu /s/ Xin Dong Director March 5, 2024 Xin Dong